Intellia Therapeutics, Inc.
NTLA
$9.20
-$0.40-4.17%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -16.25% | -8.60% | -4.77% | -12.67% | -13.26% |
| Total Receivables | 23.33% | -3.81% | -28.19% | -66.15% | -0.08% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 24.50% | -32.10% | -18.36% | -4.45% | 18.45% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -13.83% | -9.99% | -6.12% | -14.35% | -11.45% |
|
|
|||||
| Total Current Assets | -13.83% | -9.99% | -6.12% | -14.35% | -11.45% |
| Net Property, Plant & Equipment | -33.88% | 91.08% | -4.86% | -4.78% | -3.80% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 150.50% | 3.31% | 0.10% | -4.37% | -2.96% |
| Total Assets | -17.20% | 1.51% | -1.53% | -5.40% | -3.18% |
|
|
|||||
| Total Accounts Payable | -15.25% | 10.99% | -30.14% | 37.45% | 83.70% |
| Total Accrued Expenses | -26.28% | 11.03% | 16.49% | 8.96% | -34.67% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 91.46% | 5.57% | 1.13% | 1.07% | 0.88% |
| Total Finance Division Other Current Liabilities | 0.00% | -12.10% | -4.11% | -6.37% | -9.82% |
| Total Other Current Liabilities | 0.00% | -12.10% | -4.11% | -6.37% | -9.82% |
| Total Current Liabilities | 1.57% | 4.89% | 0.56% | 7.33% | -15.01% |
|
|
|||||
| Total Current Liabilities | 1.57% | 4.89% | 0.56% | 7.33% | -15.01% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -57.63% | 130.40% | -5.59% | -5.18% | -4.80% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -27.91% | -19.25% | -19.41% | -16.11% | -13.93% |
| Total Liabilities | -35.36% | 51.40% | -4.42% | -1.33% | -10.91% |
|
|
|||||
| Common Stock & APIC | 0.72% | 1.36% | 4.26% | 2.93% | 3.40% |
| Retained Earnings | -5.25% | -6.29% | -7.09% | -8.32% | -6.48% |
| Treasury Stock & Other | 74.71% | -81.65% | 385.45% | -21.96% | 58.06% |
| Total Common Equity | -10.56% | -9.42% | -0.87% | -6.28% | -1.34% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -10.56% | -9.42% | -0.87% | -6.28% | -1.34% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -10.56% | -9.42% | -0.87% | -6.28% | -1.34% |
|
|
|||||